About Wohua Pharmaceutical Company

Wohua Pharmaceutical (stock code: 002107) is a listed company specializing in the field of cardiovascular and cerebrovascular Chinese patent medicines. It is headquartered in Weifang, Shandong and has a long history of more than 300 years, which can be traced back to the Qianlong period of the Qing Dynasty. Wanhetang Pharmacy.

The company was successfully restructured from the state-owned Weifang Traditional Chinese Medicine Factory into a private limited liability company in 2002, and was listed on the Shenzhen Stock Exchange on January 24, 2007.

Wohua Pharmaceutical’s main business focuses on the research and development, production and sales of cardiovascular and cerebrovascular Chinese patent medicines, and is committed to providing patients with high-quality Chinese medicine treatment options. The company owns a subsidiary, Jiangxi Wohua Jishun Pharmaceutical, with relatively strong overall strength. However, according to the reference information provided, Mr. Zhao Bingxian, the company’s chairman and actual controller, has recently been placed under detention for cooperating with the supervisory committee, which may have a certain impact on the company’s operations and future development.

In general, Wohua Pharmaceutical, as a listed company with a long history and specialized fields, has strong strength in the research and development and marketing of traditional Chinese medicine. Under the influence of the actual controller's retention incident, the company's future trend still needs to be paid close attention to.

Business Philosophy

Wohua Medicine always adheres to the business philosophy of "good people, good medicine, good medicine, good people". To make good medicine, we must first be good people, with real materials and continuous improvement. Become the nature and tradition of Wohua Pharmaceutical. We have always regarded quality as the cornerstone of corporate survival, and strived to build a modern traditional Chinese medicine industry chain that meets industry standards. We have invested heavily in purchasing domestic first-class advanced equipment, and comprehensively renovated our production workshops. By the end of 2003, all of the company's dosage forms had passed GMP certification. A Chinese herbal medicine planting base that complies with GAP is under preparation.

We have established a strong quality assurance system from the purchase of medicinal materials to the entire process of production and after-sales service. In recent years, in the quality inspections conducted by national, provincial and municipal drug inspection departments, the raw materials and finished products sampled have all passed the inspection, and have been awarded "Quality Star Enterprise" and "Reliable Drug" by the provincial and municipal Food and Drug Administration many times. Factory" and other honorary titles.

By implementing academic, service and cultural marketing, while transforming and standardizing the marketing system, the market resources are in the hands of the company, and the budget system input-output assessment is implemented, which basically eliminates the waste of marketing expenses and ineffective investment. In the past few years, under the premise of budgetary control of sales expense ratio, sales revenue has achieved substantial growth.

The above content refers to Baidu Encyclopedia-Wohua Medicine